Uptake of PSMA-ligands in normal tissues is dependent on tumor load in patients with prostate cancer

Radioligand therapy (RLT) with Lu-177-labeled PSMA-ligands is a new therapy option for prostate cancer. Biodistribution in normal tissues is of interest for therapy planning. We evaluated if the biodistribution of Ga-68-PSMA-11 is influenced by tumor load. RESULTS: In patients with high tumor load,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaertner, Florian C., Halabi, Khalil, Ahmadzadehfar, Hojjat, Kürpig, Stefan, Eppard, Elisabeth, Kotsikopoulos, Charalambos, Liakos, Nikolaos, Bundschuh, Ralph A., Strunk, Holger, Essler, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589644/
https://www.ncbi.nlm.nih.gov/pubmed/28903405
http://dx.doi.org/10.18632/oncotarget.19049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589644/
https://www.ncbi.nlm.nih.gov/pubmed/28903405
http://dx.doi.org/10.18632/oncotarget.19049

Ejemplares similares